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Abstract: Research on Mediterranean diet (MD) adherence and musculoskeletal health is limited.
The current study determined if adherence to the alternative MD score (aMED) and MD score (MDS),
quantified from 7-d food diaries, was associated with fracture incidence, bone density (calcaneal
broadband ultrasound attenuation (BUA)) and fat free mass (expressed over BMI (FFMBMI) using
bioelectrical impedance) in 25,450 men and women recruited to the European Prospective Investigation
into Cancer study in Norfolk, UK. During 17.4 years of follow up (443,178 total person years) 2195
incident fractures occurred. Higher aMED adherence was associated with 23% reduced total (Q5–Q1
HR 0.77; 95% CI 0.67, 0.88; p-trend < 0.01) and 21% reduced hip (Q5–Q1 HR 0.79; 95% CI 0.65, 0.96;
p-trend = 0.01) fracture incidence, and significantly higher BUA (Q5–Q1 1.0 dB/MHz 95% CI 0.2, 1.9;
p-trend < 0.01) and FFMBMI (Q5–Q1 0.05 kg/(kg/m2) 95% CI 0.04, 0.06; p-trend < 0.01), comparing
extreme adherence quintiles. Higher MDS was also associated with reduced total fractures (Q5–Q1
HR 0.83; 95% CI 0.71, 0.96; p-trend = 0.03) and significantly higher BUA (Q5–Q1 1.4 dB/MHz 95%
CI 0.5, 2.3; p-trend < 0.01) and FFMBMI (Q5–Q1 0.03 kg/(kg/m2) 95% CI 0.01, 0.04; p-trend < 0.01).
This evidence supports the need to develop interventions to enhance MD adherence, particularly in
women, where evidence for associations was stronger.
Keywords: Mediterranean diet; fracture; muscle
1. Introduction
A Mediterranean diet is widely recommended for the primary prevention of nutrition-related non
communicable diseases including cardiovascular diseases, cancer and type 2 diabetes [1,2]. Data from
randomised controlled trials and prospective cohort studies also show that a Mediterranean diet may
be protective for musculoskeletal health [3,4] although the research is limited [5]. A Mediterranean
diet is characterised by high intake of plant-based foods (fruit, vegetables, nuts and cereals) and olive
oil, moderate intake of fish and alcohol and low intake of dairy products and red and processed
meat [6]. Nutritional constituents of foods abundant in Mediterranean diets such as antioxidants
(including vitamin C, carotenoids, selenium, magnesium) and fibre (abundant in plant foods) have
been associated with beneficial effects on musculoskeletal health [7]. Likewise, polyphenols (abundant
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in fruit, vegetables and olive oil), and omega-3 fatty acids (abundant in fish) have been shown to
protect against bone loss [8,9]. The pathways of action for antioxidants and polyphenols in bone
remodelling include suppressing osteoclast activity and promoting osteoblast differentiation [10].
The n-3 and n-6 omega-3 fatty acids have been shown to inhibit inflammatory cytokine expression,
stimulate prostaglandin E2 production and enhance calcium transport [11]. Whilst individual dietary
constituents within the Mediterranean diet have an important role in musculoskeletal health, it is
likely the interactive and synergistic effects of these individual components have a greater combined
impact [12].
It is well established that both low bone mass and skeletal muscle mass increase susceptibility to
low impact fragility fractures. Furthermore, skeletal muscle and bone health appear to be related with
bone tissue shown to be responsive to alterations in skeletal muscle contraction and myokines secreted
by the muscle, including insulin-like growth factor 1 and fibroblast growth factor 2, stimulating bone
growth and repair [13,14]. This means that a decline in muscle mass is likely to have a corresponding
impact on bone health. The aim of the current study was therefore to examine associations between
adherence to a Mediterranean diet and key indicators of bone and muscle status, including fracture
incidence, bone density and fat free mass in a large longitudinal cohort of 25,450 men and women
living in the UK. We also examined the associations between our bone and muscle status indicators
and fracture risk in order to ascertain their value for prediction of fracture risk with a longer follow-up
period than previously reported. Earlier studies examining the associations between Mediterranean diet
adherence, bone density and fat free mass (FFM) have been restricted by limited sample sizes [15–17].
In addition, this will be the first study to use food diaries to examine Mediterranean diet adherence in
a large longitudinal study of fracture risk.
2. Materials and Methods
2.1. Study Population
The European Prospective Investigation into Cancer (EPIC) in Norfolk is a population-based
prospective cohort of 25,450 men and women in the UK arm of the multicentre EPIC study (Figure 1).
The EPIC Norfolk study design and the characteristics of the cohort have been described previously [18].
Briefly, all men and women aged between 39 to 79 years between 1993 and 1997 who were registered
with 35 collaborating general practice surgeries in the Norfolk area were invited to the study by mail
and attended a baseline health check. The study was approved by the Norwich District Authority Ethics
Committee (98CN01) and was conducted according to the Declaration of Helsinki. All participants
provided informed consent.
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Of the recruited participants, 14,815 agreed to take part in a follow-up examination between 1998 
and 2000 (second health check), at which point quantitative ultrasound measurements of the 
calcaneus was performed using a CUBA Clinical Ultrasonometer (McCue Ultrasonics). 
Measurements of broadband ultrasound attenuation (BUA in dB/MHz) and velocity of sound (VOS 
in m/s) were taken in duplicate from each foot. The means of the left and right measurements were 
used for analysis. The coefficient of variation was 3.5%. Five CUBA machines were used and 
calibrated daily with a physical phantom. The machines were also compared on one calcaneus, and 
whilst significant variations between machines arose, adjustment for temperature and machine were 
not found to change BUA–fracture relations [19]. Analysis in this cohort also showed that the power 
of quantitative ultrasound for the prediction of fractures is comparable to that of dual-energy x-ray 
absorptiometry (DXA) with the hazard ratio for a 1 SD decrease in DXA-measured total hip bone 
mineral density was 2.3 (95% CI: 1.7–3.0) compared with 2.0 (95% CI: 1.6–2.7) for a 1 SD decrease in 
BUA [20]. 
Bioelectrical impedance analysis (BIA) was also undertaken using a standardised technique 
(Tanita TBF-531, Bodystat, Isle of Man, UK). The machine had two toe and two heel electrodes. Body 
density (BD) was calculated from weight, height, and impedance (Z) using standard regression 
formulas for adults: 
BD in men =1.100455–0.109766 × weight (kg) × Z / height (cm)2 + 0.000174 × Z  
Figure 1. A flow chart detailing participant recruitment for the European Prosp cti Investigation
of Cancer.
2.2. Outcome Assessment
Of the recruited participants, 14,815 agreed to take part in a follow-up examination between
1998 and 2000 (second health check), at which point quantitative ultrasound measurements of the
calcaneus was performed using a CUBA Clinical Ultrasonometer (McCue Ultrasonics). Measurements
of broadband ultrasound attenuation (BUA in dB/MHz) and velocity of sound (VOS in m/s) were taken
in duplicate from each foot. The means of the left and right measurements were used for analysis.
The coefficient of variation was 3.5%. Five CUBA machines were used and calibrated daily with
a physical phantom. The machines were also compared on one calcaneus, and whilst significant
variations between machines arose, adjustment for temperature and machine were not found to
change BUA–fracture relations [19]. Analysis in this cohort also showed that the power of quantitative
ultrasound for the prediction of fractures is comparable to that of dual-energy x-ray absorptiometry
(DXA) with the hazard ratio for a 1 SD decrease in DXA-measured total hip bone mineral density was
2.3 (95% CI: 1.7–3.0) compared with 2.0 (95% CI: 1.6–2.7) for a 1 SD decrease in BUA [20].
Bioelectrical impedance analysis (BIA) was also undertaken using a standardised technique (Tanita
TBF-531, Bodystat, Isle of Man, UK). The machine had two toe and two heel electrodes. Body density
(BD) was calculated from weight, height, and impedance (Z) using standard regression formulas
for adults:
BD in men = 1.100455 – 0.109766 × weight (kg) × Z/height (cm)2 + 0.000174 × Z
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BD in women = 1.090343 – 0.108941 × weight (kg) × Z/height (cm)2 + 0.00013 × Z.
From this, fat free mass (FFM) in kg was calculated:
FFM = weight (kg) − ((4.57/BD − 4.142) × weight (kg))
This estimates the total mass of non-fat compartments of the body, i.e., metabolic tissue, intra- and
extra-cellular water, and bone tissue. For analysis, we standardised FFM by dividing values by BMI
(FFMBMI) [21]. The correlation between DXA and BIA-calculated fat free mass is high (0.95) [22].
Osteoporotic fractures were identified using the East Norfolk Health Authority database which
records all hospital contact that Norfolk residents have in England and Wales. International
Classification of Disease codes 9 and 10 diagnostic codes were used to ascertain fractures by site. Data
were available to 31st March 2016. We defined total fractures as any incident fracture at the hip, spine
or wrist.
2.3. Assessment of Dietary Intakes
Food and nutrient intakes were estimated from seven-day food diaries completed at one time
point (first health check (1993–1997), as described previously [23]. For the first day of the diary,
a nurse conducted a 24-h diet recall according to a standardised protocol, with the remaining six
days completed by the participant at home. Data were entered by using the Data into Nutrients for
Epidemiologic Research (DINER) data entry system [24]. We calculated adherence to the original
Mediterranean Diet Score (MDS) developed by Trichopoulou et al. [6] and the alternate Mediterranean
Diet Index (aMED), as developed by Fung et al. [25]. The indices are based on the dietary intake of
nine components (MDS: vegetables, legumes, fruit and nuts, dairy, cereals, meat and meat products,
fish, alcohol, and the ratio of monounsaturated to saturated fat and aMED: vegetables, legumes, fruit,
nuts, whole grains, red and processed meat, fish, alcohol, and the ratio of monounsaturated fat to
saturated fat). Each component receives one point if intake is above the sex-specific median except for
meat and, for the MDS only, dairy (where one point is scored if consumption is less than the median
intake). For alcohol, one point is given for intake between 5–25 g/d in the aMED and MDS (women
only) or between 10–50 g/day for men in the MDS. The final scores range between 0 and 9 with a higher
score implying greater adherence. The key difference between these two indices of Mediterranean diet
adherence is the scoring of dairy products, which are scored negatively in the MDS and eliminated in
the aMED. As a result, we expected that the nutrient profiles of high MDS and aMED adherers would
vary—in particular, calcium and protein intake, which are rich in dairy products.
2.4. Assessment of Covariates
Participants completed a Health and Lifestyle Questionnaire at each health check which included
questions on past year physical activity, from which a simple four-level physical activity index was
derived [26], smoking status, medication use, menopausal status and family history of medical
conditions. Trained nurses measured height and weight, from which BMI was calculated. We estimated
the ratio of energy intake to estimated energy requirements (EER) (100 × (energy intake (kcal)/EER)
with EER determined using the Institute of Medicine equations by BMI, age and sex [27].
2.5. Statistical Analysis
The characteristics of participants were presented as means (SD) and n (%) for categorical variables
and compared between men and women using independent t-tests or chi-square tests at the first
(1993–1997) and second (1998–2000) health checks. We examined the associations between aMED
and MDS adherence and dietary intakes at the first health check using ANCOVA with sex, age, BMI,
smoking, physical activity, days of dietary intake data, and the ratio of energy intake to EER (as a
measure of energy misreporting) included in the models. Multivariable cox proportional-hazard models
were used to determine the associations between incident fractures and measures of quantitative
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ultrasound (BUA and VOS) and FFMBMI with sex, age, BMI, smoking, physical activity, family
history of osteoporosis, medication use (corticosteroids, aspirin or hormone replacement therapy) and
menopausal status included as covariates. We then modelled the associations between aMED and
MDS adherence and incident fractures with additional adjustment for calcium intake, supplement
use (vitamin D or calcium), days of dietary intake data and the ratio of energy intake to EER as a
measure of energy misreporting, both in the whole cohort and stratified by sex. Models with the
same adjustments were used to examine associations between individual dietary components of the
aMED and MDS scores and incident fracture. In these analyses, we compared participants above
and below median intakes and included all components. Finally, we investigated the associations
between aMED and MDS adherence and BUA, VOS and FFMBMI at the second health check using
ANCOVA with adjustment for all covariates (sex, age, BMI, smoking, physical activity, family history
of osteoporosis, medication use, menopausal status, calcium intake, supplement use (vitamin D or
calcium), days of dietary intake data and the ratio of energy intake to EER). Participants were ranked
into quintiles of aMED and MDS adherence for all analyses. Tests for trends were conducted using the
median value for each quintile as a continuous variable. p values < 0.05 was considered statistically
significant. Statistical analyses were performed using Stata software (version 16; College Station, TX,
USA: StataCorp LLC).
3. Results
Our analysis included 25,453 participants aged between 39 and 79 y at baseline (mean 59.3 ±
9.3 years), of which 55% were women (Table 1). During follow up (mean 17.4 y; 443,178 total person
years) there were 2195 incident spine, wrist and hip fractures (n = 467 men and n = 1167 women), of
which 49% were hip fractures. Women had a 6.1% higher total fracture incidence than men (p < 0.01).
Measurements of BUA, VOS and FFMBMI were taken at the second health check when participants
were 62.2 years old (± 9.0, range 42–82) and all were significantly lower in women compared to men
(p < 0.01 for all).
Table 1. Characteristics of participants in the EPIC Norfolk study at the first (n = 25,450) and second
(n = 14,815) health checks, stratified by sex 1.
1st Health Check (1993–1997) 2nd Health Check (1998–2000)
All
(n = 25,450)
Men
(n = 11,511)
Women
(n = 13,939) p=
All
(n = 14,815)
Men
(n = 6490)
Women
(n = 8325) p=
Age, years 59.3 ± 9.3 59.7 ± 9.3 58.9 ± 9.3 <0.01 62.2 ± 9.0 62.9 ± 9.0 61.6 ± 9.0 <0.01
Fracture, y 2195 (8.6) 610 (5.3) 1585 (11.4) <0.01 - - - -
BUA, dB/MHz - - - - 79.9 ± 19.2 90.1 ± 17.5 72.1 ± 16.5 <0.01
VOS, m/s - - - - 1634 ± 41.4 1645 ± 39.9 1625 ± 40.2 <0.01
BMI, kg/m2 26.4 ± 3.9 26.5 ± 3.3 26.2 ± 4.4 <0.01 26.7 ± 4.0 26.9 ± 3.3 26.5 ± 4.4 <0.01
FFM (kg) - - - - 49.8 ± 11.8 61.7 ± 6.0 40.6 ± 4.8 <0.01
FFMBMI (kg/(kg/m2)) - - - - 1.9 ± 0.5 2.3 ± 0.3 1.6 ± 0.3 <0.01
Current smoking, y 3170 (12.5) 1472 (12.8) 1698 (12.2) <0.01 1243 (8.5) 540 (8.4) 703 (8.6) <0.01
Physically active, y 4610 (18.1) 2479 (21.5) 2131 (15.3) <0.01 2825 (19.4) 1431 (22.4) 1394 (17.0) <0.01
Family history of
osteoporosis, y 1117 (4.4) 307 (2.7) 810 (5.8) <0.01 686 (4.7) 174 (2.7) 512 (6.3) <0.01
Vitamin D supplements, y 6849 (26.9) 2570 (22.3) 4279 (30.7) <0.01 4335 (29.7) 1599 (25.0) 2736 (33.5) <0.01
Calcium supplements, y 911 (3.6) 165 (1.4) 746 (5.4) <0.01 598 (4.1) 98 (1.5) 500 (6.1) <0.01
Corticosteroid or aspirin, y 2687 (10.6) 1508 (13.1) 1179 (8.5) <0.01 1667 (11.4) 883 (13.8) 784 (9.6) <0.01
HRT, y - - 2824 (20.3) - - - 1732 (21.2) -
Postmenopausal, y - - 8351 (59.9) - - - 6002 (73.4) -
aMED, points 4.0 ± 1.7 4.0 ± 1.7 4.0 ± 1.7 0.19 4.1 ± 1.7 4.1 ± 1.7 4.1 ± 1.7 0.02
MDS, points 4.3 ± 1.6 4.4 ± 1.6 4.2 ± 1.6 <0.01 4.33 ± 1.59 4.40 ± 1.60 4.28 ± 1.58 <0.01
Energy intake, kcal/d 1941 ± 534 2240 ± 527 1694 ± 395 <0.01 1974 ± 517 2285 ± 502 1731 ± 380 <0.01
Calcium intakes, mg/d 835 ± 282 919 ± 297 766 ± 248 <0.01 853 ± 275 942 ± 289 784 ± 243 <0.01
Vitamin D intakes, mg/d 3.3 ± 2.4 3.7 ± 2.7 2.9 ± 2.1 <0.01 3.4 ± 2.4 3.9 ± 2.8 3.0 ± 1.9 <0.01
1 Values are means ± SD or n = (%), n = 25,438. p values are for the difference between men and women using t-test
for continuous variables and χ2 for categorical variables. Fat free mass was measured in n = 14,720 (n = 6446 men
and n = 8274 women) at the second health check. aMED = Alternative Mediterranean Diet Score; BUA = broadband
ultrasound attenuation; FFM = fat free mass; HRT = hormone replacement therapy; MDS = Mediterranean Diet
Score; VOS = velocity of sound; y=yes.; d = day.
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There were significant trends for lower fracture risk across increasing quintiles of BUA (Q5 vs. Q1
HR 0.32; 95% CI 0.26, 0.40; p-trend < 0.01), VOS (Q5 vs. Q1 HR 0.33; 95% CI 0.26, 0.41; p-trend < 0.01)
and FFMBMI (Q5 vs. Q1 HR 0.56 95% CI 0.43, 0.74; p-trend < 0.01) after adjustment for sex, age, BMI,
smoking, physical activity, family history of osteoporosis, medication use and menopausal status
(Figure 2).
Nutrients 2020, 12, x FOR PEER REVIEW 6 of 15 
 
There were significant trends for lower fracture risk across increasing quintiles of BUA (Q5 vs. 
Q1 HR 0.32; 95% CI 0.26, 0.40; P-trend < 0.01), VOS (Q5 vs. Q1 HR 0.33; 95% CI 0.26, 0.41; P-trend < 
0.01) and FFMBMI (Q5 vs. Q1 HR 0.56 95% CI 0.43, 0.74; P-trend < 0.01) after adjustment for sex, age, 
BMI, smoking, physical activity, family history of osteoporosis, medication use and menopausal 
status (Figure 2). 
 
Figure 2. Total fracture risk after a mean follow up of 17.6 years by quintile of broadband ultrasound 
attenuation, velocity of sound and fat free mass in 14,911 men and women aged 39–79 years. Values 
are adjusted hazard ratios (95% CI), n = 14,911. Ratios were adjusted for sex, age, BMI, smoking, 
physical activity, family history of osteoporosis, medication use (corticosteroids, aspirin or hormone 
replacement therapy) and menopausal status. BMI was not included in the FFMBMI model. P values 
are for trends calculated using the Cox proportional hazards model. Participant numbers (cases) per 
quintile were as follows; BUA: Q1 = 2985 (505), Q2 = 2981 (266), Q3= 2981 (213), Q4= 2982 (157), Q5 = 
2982 (105). VOS: Q1 = 2994 (464), Q2 = 2989 (292), Q3 = 2991 (224), Q4 = 2972 (172), Q5 = 2965 (94). 
FFMBMI: Q1 = 2960 (308), Q2 = 2959 (325), Q3 = 2959 (270), Q4 = 2959 (182), Q5 = 2959 (145). BUA = 
broadband ultrasound attenuation; VOS = velocity of sound; FFMBMI = fat free mass adjusted for BMI 
Higher aMED and MDS adherence was associated with significantly higher intakes of energy 
(aMED Q5 vs. Q1 13.0 kcal; 95% CI 7.3, 18.7; P-trend < 0.01, MDS Q5 vs. Q1 17.7 kcal; 95% CI 11.5, 
23.9; P-trend < 0.01), vitamin C (aMED Q5 vs. Q1 42.1 mg; 95% CI 40.2, 44.1; P-trend < 0.01, MDS Q5 
vs. Q1 33.8 mg; 95% CI 31.6, 35.9; P-trend < 0.01), magnesium (aMED Q5 vs. Q1 78.6 mg; 95% CI 76.1, 
81.1; P-trend < 0.01, MDS Q5 vs. Q1 46.3 mg; 95% CI 43.5, 49.2; P-trend < 0.01) and potassium (aMED 
Q5 vs. Q1 656 mg; 95% CI 633, 678; P-trend < 0.01, MDS Q5 vs. Q1 380 mg; 95% CI 355, 406; P-trend < 
0.01) (Table S1 and Table S2). Energy adjusted intakes of saturated (aMED Q5 vs. Q1 −3.3%; 95% CI 
−3.4, −3.2; P-trend <0.01, MDS Q5 vs. Q1 −3.5%; 95% CI −3.6, −3.4; P-trend < 0.01) and 
monounsaturated fats (aMED Q5 vs Q1 −0.6%; 95% CI −0.6, −0.5; P-trend < 0.01, MDS Q5 vs. Q1 −0.7%; 
95% CI −0.8, −0.6; P-trend < 0.01) were lower with increasing adherence, although the ratios of 
monounsaturated to saturated fats and polyunsaturated fat intakes were higher (aMED Q5 vs. Q1 
0.20; 95% CI 0.19, 0.21; P-trend < 0.01, MDS Q5 vs. Q1 0.20; 95% CI 0.19, 0.21; P-trend < 0.01). Higher 
adherence to the MDS, which scores dairy products negatively, was associated with significantly 
lower calcium intakes (Q5 vs. Q1 −78.9 mg; 95% CI −88.3, −69.5; P-trend < 0.01) with no difference 
observed for protein intake (Q5 vs. Q1 −0.1 %; 95% CI −0.2, 0.0; P-trend = 0.19). Conversely, higher 
aMED adherence, which does not account for dairy intake, was associated with higher intakes of 
calcium (Q5 vs. Q1 23.3 mg; 95% CI 14.5, 32.0; P-trend < 0.01) and protein (Q5 vs. Q1 0.9%; 95% CI 
0.8, 1.0; P-trend < 0.01). 
In multivariable analysis, in the whole cohort there was a significant inverse trend for reduced 
total fracture risk across increasing quartiles of aMED adherence (Q5 vs. Q1 HR 0.77; 95% CI 0.67, 
0.88; P-trend < 0.01) (Figure 3) adjusted for relevant confounding variables. 
Figure 2. Total fracture risk after a mean follow up of 17.6 years by quintile of broadband ultrasound
attenuation, velocity of sound and fat free mass in 14,911 men and women aged 39–79 years. Values are
adjusted hazard ratios (95% CI), n = 14,911. Ratios were adjusted for sex, age, BMI, smoking, physical
activity, family history of osteoporosis, medication use (corticosteroids, aspirin or hormone replacement
therapy) and menopausal status. BMI was not included in the FFMBMI model. p values are for trends
calculated using the Cox proportional hazards model. Participant numbers (cases) per quintile were as
follows; BUA: Q1 = 2985 (505), Q2 = 2981 (266), Q3 = 2981 (213), Q4 = 2982 (157), Q5 = 2982 (105). VOS:
Q1 = 2994 (464), Q2 = 2989 (292), Q3 = 2991 (224), Q4 = 2972 (172), Q5 = 2965 (94). FFMBMI: Q1 = 2960
(308), Q2 = 2959 (325), Q3 = 2959 (270), Q4 = 2959 (182), Q5 = 2959 (145). BUA = broadband ultrasound
attenuation; VOS = velocity of sound; FFMBMI = fat free mass adjusted for BMI
Higher aMED and MDS adherence was associated with significantly higher intakes of energy
(aMED Q5 vs. Q1 13.0 kcal; 95% CI 7.3, 18.7; p-trend < 0.01, MDS Q5 vs. Q1 17.7 kcal; 95% CI 11.5, 23.9;
p-trend < 0.01), vitamin C (aMED Q5 vs. Q1 42.1 mg; 95% CI 40.2, 44.1; p-trend < 0.01, MDS Q5 vs. Q1
33.8 mg; 95% CI 31.6, 35.9; p-trend < 0.01), magnesium (aMED Q5 vs. Q1 78.6 mg; 95% CI 76.1, 81.1;
p-trend < 0.01, MDS Q5 vs. Q1 46.3 mg; 95% CI 43.5, 49.2; p-trend < 0.01) and potassium (aMED Q5
vs. Q1 656 mg; 95% CI 633, 678; p-trend < 0.01, MDS Q5 vs. Q1 380 mg; 95% CI 355, 406; p-trend <
0.01) (Tables S1 and S2). Energy adjusted intakes of saturated (aMED Q5 vs. Q1 −3.3%; 95% CI −3.4,
−3.2; p-trend < 0.01, MDS Q5 vs. Q1 −3.5%; 95% CI −3.6, −3.4; p-trend < 0.01) and monounsaturated
fats (aMED Q5 vs Q1 −0.6%; 95% CI −0.6, −0.5; p-trend < 0.01, MDS Q5 vs. Q1 −0.7%; 95% CI −0.8,
−0.6; p-trend < 0.01) were lower with increasing adherence, although the ratios of monounsaturated to
saturated fats and polyunsaturated fat intakes were higher (aMED Q5 vs. Q1 0.20; 95% CI 0.19, 0.21;
p-trend < 0.01, MDS Q5 vs. Q1 0.20; 95% CI 0.19, 0.21; p-trend < 0.01). Higher adherence to the MDS,
which scores dairy products negatively, was associated with significantly lower calcium intakes (Q5 vs.
Q1 −78.9 mg; 95% CI −88.3, −69.5; p-trend < 0.01) with no difference observed for protein intake (Q5
vs. Q1 −0.1 %; 95% CI −0.2, 0.0; p-trend = 0.19). Conversely, higher aMED adherence, which does not
account for dairy intake, was associated with higher intakes of calcium (Q5 vs. Q1 23.3 mg; 95% CI
14.5, 32.0; p-trend < 0.01) and protein (Q5 vs. Q1 0.9%; 95% CI 0.8, 1.0; p-trend < 0.01).
In multivariable analysis, in the whole cohort there was a significant inverse trend for reduced
total fracture risk across increasing quartiles of aMED adherence (Q5 vs. Q1 HR 0.77; 95% CI 0.67, 0.88;
p-trend < 0.01) (Figure 3) adjusted for relevant confounding variables.
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0.65, 0.96; p-trend = 0.01) but not MDS (Q5 vs. Q1 HR 0.85; 95% CI 0.69, 1.04; p-trend = 0.24) adherence
(data not shown).
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Of the individual components of the aMED score, intakes above the median of legumes (HR 0.91;
95% CI 0.84, 0.99; p-trend = 0.04), nuts and seeds (HR 0.86; 95% CI 0.77, 0.96; p-trend = 0.01), and
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alcohol intake (HR 0.91; 95% CI 0.83, 0.99; p-trend = 0.04) were associated with reduced fracture risk in
mutually adjusted models, whereas intake below the median of red and processed meat (HR 0.91; 95%
CI 0.83, 0.99; P-trend = 0.03) was associated with reduced fracture risk. No associations were observed
for individual components of the MDS (Table 2).
Table 2. Total fracture risk after a mean follow up of 17.6 years by individual components of the
alternative Mediterranean Diet Score and Mediterranean Diet Score in 25,450 men and women aged
39–79 years 1.
Score Component Hazard Ratio (95% CI) p-Value
aMED Vegetables, g/d 0.93 (0.86, 1.02) 0.13
Legumes, g/d 0.91 (0.84, 1.00) 0.04
Fruit, g/d 0.97 (0.89, 1.06) 0.53
Fish, g/d 1.01 (0.93, 1.11) 0.76
Nuts and seeds, g/d 0.86 (0.77, 0.96) 0.01
Wholegrains, g/d 1.01 (0.92, 1.10) 0.89
Red and processed meat, g/d 0.91 (0.83, 0.99) 0.03
Ratio MUFA: SFA 1.03 (0.94, 1.12) 0.57
Alcohol, g/d 0.91 (0.83, 0.99) 0.04
MDS
Vegetables, g/d 0.94 (0.86, 1.02) 0.14
Legumes, g/d 0.92 (0.84, 1.00) 0.06
Fruit and nuts, g/d 0.97 (0.89, 1.06) 0.54
Fish, g/d 1.01 (0.92, 1.10) 0.85
Cereals, g/d 0.99 (0.90, 1.09) 0.82
Dairy, g/d 0.94 (0.84, 1.05) 0.28
Meat and eggs, g/d 0.96 (0.88, 1.05) 0.38
Ratio MUFA: SFA 1.01 (0.93, 1.11) 0.76
Alcohol, g/d 0.93 (0.85, 1.02) 0.13
1 Values are the adjusted hazard ratios (95% CI) comparing participants with intakes above vs. below the median
for each component (except the Meat and Dairy components, which compare participants with intakes below vs.
above the median). Ratios were adjusted for sex, age, BMI, smoking, physical activity, family history of osteoporosis,
calcium intakes, supplement use (vitamin D or calcium), medication use (corticosteroids, aspirin or hormone
replacement therapy), menopausal status, days of dietary intake data and the ratio of energy intake to estimated
energy requirements. As each component was included simultaneously in the same model, values are mutually
adjusted for the other components. d: day.
We also observed significant positive trends between higher BUA and VOS across increasing
quintiles of aMED adherence (Q5 vs. Q1 BUA = 1.0 dB/MHz 95% CI 0.2, 1.9; p-trend < 0.01 and
VOS = 2.3 m/s 95% CI 0.3, 4.2; p-trend < 0.01, Table 3). Stratification by sex revealed significant
associations between aMED adherence and BUA only in women (Q5 vs. Q1 1.2 dB/MHz 95% CI 0.2, 2.2;
p-trend < 0.01). Likewise, there was a significant positive association between higher aMED adherence
and FFMBMI (Q5 vs. Q1 0.05 kg/(kg/m2) 95% CI 0.04, 0.06; p-trend < 0.01) which was observed in both
men (Q5 vs Q1 0.05 kg/(kg/m2) 95% CI 0.03, 0.06; p-trend < 0.01) and women (Q5 vs. Q1 0.05 kg/(kg/m2)
95% CI 0.03, 0.07; p-trend < 0.01). The associations between aMED adherence and FFM expressed in
kg were unchanged ((Q5 vs. Q1 0.92 kg 95% CI 0.65, 1.19; p-trend < 0.01, Table S3). The unadjusted
associations between BUA, VOS and FFMBMI and aMED adherence are presented in Table S4.
For the MDS, there was a significant positive trend between higher adherence and higher BUA in
the whole cohort (Q5 vs. Q1 1.4 dB/MHz 95% CI 0.5, 2.3; p-trend < 0.01) and in women (Q5 vs. Q1
0.9 dB/MHz 95% CI −0.2, 1.9; p-trend = 0.02) (Table 4). There was also a significant positive association
between higher MDS adherence and FFMBMI in the whole cohort (Q5 vs. Q1 0.03 kg/(kg/m2) 95% CI
0.01, 0.04; p-trend < 0.01) and in both men (Q5 vs. Q1 0.02 kg/(kg/m2) 95% CI 0.01, 0.05; p-trend = 0.02)
and women (Q5 vs. Q1 0.03 kg/(kg/m2) 95% CI 0.01, 0.05; p-trend < 0.01). There were also significant
associations between higher MDS adherence and FFM expressed in kg ((Q5 vs. Q1 1.21 kg 95% CI 0.92,
1.51; p-trend < 0.01, Table S3). We observed no significant associations between MDS adherence and
Nutrients 2020, 12, 1154 10 of 15
VOS. The unadjusted associations between BUA, VOS and FFMBMI and MDS adherence are presented
in Table S5.
Table 3. Measures of broadband ultrasound attenuation, velocity of sound and fat free mass by quintile
of alternative Mediterranean Diet Score in 14,815 men and women aged 42–82 years, stratified by sex 1.
Sex Quintile BUA (dB/MHz) VOS (m/s) FFMBMI (kg/(kg/m2))
n = Mean (95% CI) n = Mean (95% CI) n= Mean (95% CI)
All Q1 2725 79.5 (78.9,80.1) 2725 1632 (1631,1634) 2711 1.87 (1.86,1.88)
Q2 2865 79.3 (78.7,79.8) 2865 1632 (1631,1634) 2848 1.88 (1.87,1.89)
Q3 3240 80.2 (79.7,80.7) 3240 1634 (1633,1636) 3212 1.90 (1.89,1.91)
Q4 2928 80.1 (79.5,80.7) 2928 1634 (1633,1635) 2914 1.90 (1.89,1.91)
Q5 3057 80.6 (80.0,81.1) 3057 1635 (1633,1636) 3035 1.92 (1.91,1.93)
Q5–Q1 1.04 (0.22, 1.87) 2.26 (0.27, 4.24) 0.05 (0.04, 0.06)
p = <0.01 0.01 <0.01
Men Q1 1157 89.9 (88.9,90.9) 1157 1644 (1642,1646) 1155 2.30 (2.28,2.31)
Q2 1213 89.6 (88.6,90.6) 1213 1644 (1642,1646) 1208 2.31 (2.29,2.32)
Q3 1442 90.0 (89.1,90.9) 1442 1645 (1643,1648) 1423 2.31 (2.30,2.33)
Q4 1303 90.2 (89.3,91.2) 1303 1645 (1643,1647) 1299 2.33 (2.31,2.34)
Q5 1375 90.5 (89.5,91.4) 1375 1647 (1645,1649) 1361 2.34 (2.33,2.36)
Q5–Q1 0.58 (−0.80, 1.97) 2.87 (−0.27, 6.01) 0.05 (0.03, 0.07)
p = 0.25 0.06 <0.01
Women Q1 1568 71.5 (70.8,72.2) 1568 1623 (1622,1625) 1556 1.54 (1.53,1.55)
Q2 1652 71.4 (70.7,72.0) 1652 1624 (1622,1625) 1640 1.55 (1.54,1.57)
Q3 1798 72.5 (71.9,73.2) 1798 1626 (1624,1627) 1789 1.57 (1.56,1.59)
Q4 1625 72.1 (71.4,72.8) 1625 1625 (1623,1627) 1615 1.57 (1.56,1.58)
Q5 1682 72.7 (72.0,73.4) 1682 1625 (1623,1627) 1674 1.59 (1.58,1.60)
Q5–Q1 1.19 (0.20, 2.18) 1.44 (−1.07, 3.94) 0.05 (0.03, 0.07)
p = <0.01 0.14 <0.01
1 Values are adjusted means (95% CI), n = 14,815. Means were adjusted for sex, age, BMI, smoking, physical
activity, family history of osteoporosis, calcium intakes, supplement use (vitamin D or calcium), medication use
(corticosteroids, aspirin or hormone replacement therapy), menopausal status, days of dietary intake data and the
ratio of energy intake to estimated energy requirements. BMI was not included in the FFMBMI model. p values
are for trends calculated using ANCOVA. Range of aMED in each quintile was Q1 = 0 to 2 points, Q2 = 3 points.
Q3 = 4 points, Q4 = 5 points, Q5 = 6 to 9 points. BUA = broadband ultrasound attenuation; VOS = velocity of
sound; FFMBMI = fat free mass adjusted for BMI.
Table 4. Measures of broadband ultrasound attenuation, velocity of sound and fat free mass by quintile
of Mediterranean Diet Score in 14,815 men and women aged 42–82 years, stratified by sex 1.
Sex Quintile BUA (dB/MHz) VOS (m/s) FFMBMI (kg/(kg/m2))
n = Mean (95% CI) n = Mean (95% CI) n = Mean (95% CI)
All Q1 1872 79.1 (78.4,79.8) 1872 1632 (1630,1633) 1852 1.88 (1.87,1.89)
Q2 2669 79.8 (79.2,80.4) 2669 1634 (1632,1635) 2668 1.89 (1.88,1.90)
Q3 3468 79.9 (79.3,80.4) 3468 1633 (1632,1635) 3446 1.90 (1.89,1.90)
Q4 3350 80.1 (79.5,80.6) 3350 1634 (1633,1635) 3314 1.89 (1.88,1.90)
Q5 3456 80.5 (79.9,81.0) 3456 1634 (1633,1636) 3440 1.91 (1.90,1.92)
Q5–Q1 1.35 (0.45, 2.25) 2.57 (0.41, 4.73) 0.03 (0.01, 0.04)
p = <0.01 0.05 <0.01
Men Q1 754 88.9 (87.6,90.1) 754 1643 (1640,1646) 749 2.31 (2.29,2.33)
Q2 1122 90.1 (89.0,91.1) 1122 1646 (1643,1648) 1123 2.31 (2.29,2.32)
Q3 1511 90.4 (89.5,91.2) 1511 1646 (1644,1648) 1497 2.32 (2.30,2.33)
Q4 1504 89.6 (88.8,90.5) 1504 1644 (1642,1646) 1486 2.32 (2.31,2.33)
Q5 1599 90.7 (89.9,91.6) 1599 1647 (1645,1649) 1591 2.33 (2.32,2.34)
Q5–Q1 1.85 (0.33, 3.37) 3.95 (0.50, 7.40) 0.02 (0.00, 0.05)
p = 0.08 0.14 0.02
Women Q1 1118 71.6 (70.8,72.4) 1118 1623 (1621,1625) 1103 1.55 (1.53,1.56)
Q2 1547 71.8 (71.1,72.5) 1547 1625 (1623,1627) 1545 1.56 (1.54,1.57)
Q3 1957 71.6 (71.0,72.2) 1957 1624 (1622,1625) 1949 1.57 (1.56,1.58)
Q4 1846 72.6 (72.0,73.3) 1846 1626 (1625,1628) 1828 1.56 (1.55,1.57)
Q5 1857 72.5 (71.8,73.1) 1857 1624 (1623,1626) 1849 1.58 (1.57,1.59)
Q5–Q1 0.87 (−0.20, 1.93) 1.34 (−1.35, 4.04) 0.03 (0.01, 0.05)
p = 0.02 0.21 <0.01
1 Values are adjusted means (95% CI), n = 14,815. Means were adjusted for sex, age, BMI, smoking, physical
activity, family history of osteoporosis, calcium intakes, supplement use (vitamin D or calcium), medication use
(corticosteroids, aspirin or hormone replacement therapy), menopausal status, days of dietary intake data and the
ratio of energy intake to estimated energy requirements. BMI was not included in the FFMBMI model. p values
are for trends calculated using ANCOVA. Range of MDS in each quintile was Q1 = 0 to 2 points, Q2 = 3 points.
Q3 = 4 points, Q4 = 5 points, Q5 = 6 to 9 points. BUA = broadband ultrasound attenuation; VOS = velocity of
sound; FFMBMI = fat free mass adjusted for BMI.
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4. Discussion
In this large sample of men and women living in a non-Mediterranean region, greater adherence
to a Mediterranean diet was associated with up to 23% reduced total and 21% reduced hip fracture
incidence comparing extreme quintiles, with a one point increase in aMED and MDS adherence
corresponding to a 4% and 3% reduction in total fracture incidence, respectively. These associations
were greater in women than men and independent of age, BMI, smoking, physical activity, menopausal
status and medication use including hormone replacement therapy. In addition, we found that greater
Mediterranean diet adherence was associated with significantly higher BUA (1.4 dB/MHz), VOS
(2.3 m/s) and FFMBMI (0.05 kg/(kg/m2)). To our knowledge this was the first study to use food diaries
to examine Mediterranean diet adherence in a large longitudinal study of fracture risk [4,5,15,28,29].
Additional findings that higher BUA and VOS were associated with reduced fracture risk have
previously been reported in this cohort over a shorter follow-up period however, the finding that
higher FFM predicts lower fracture risk is novel [19].
These findings are consistent with those of the Women’s Health Initiative study in the US where
postmenopausal women scoring in the highest quintile of aMED adherence had 20% lower risk of hip
fracture, although no association between aMED and total fractures was observed [15]. Likewise, the
Consortium on Health and Ageing: Network of Cohorts in Europe and the United States reported
a two-point increment in adherence to the MDS corresponded to a 4% reduction in hip fracture
incidence [4]. Analysis of EPIC-Europe cohorts showed the highest quartile of MDS adherence to
be associated with a 27% reduction in hip fracture risk, equivalent to a 7% reduction per one-point
increase in MDS [28]. In the Nurses’ Health Study there was a 14% lower risk of hip fractures in the
highest compared to the lowest quintile of aMED adherence [29]. As the effect sizes in the current study
are in line with these previous reports using food frequency questionnaires to measure Mediterranean
diet adherence [4,15,28,29], it appears that dietary assessment method is not a significant factor in
determining these associations. This indicates, therefore, that the overall distribution of intakes is
more important than absolute intake values when classifying Mediterranean diet adherence within
a population.
Our previous research in a random subset of this cohort (n = 5319) with a mean follow-up time
<13.4 years showed no significant trends for total fracture risk by quintile of vitamin C, magnesium or
potassium intake, although alpha- and beta-carotene intakes were associated with up to 29% lower risk
of fractures in men only [30–32]. Whilst these dietary constituents are important components of the
Mediterranean diet and have mechanistic links with musculoskeletal health, this research suggests that
the synergistic effects of these, and other individual components, are likely to be of greater importance
in reducing fracture risk. Previous research has shown that the food matrix exhibits distinct relations
with health outcomes compared to single nutrients; for example, whole dairy products have been shown
to have a greater effect on bone mass than single dairy constituents, such as calcium and vitamin D [33].
A particular strength of the current study was the inclusion of data on musculoskeletal risk factors,
including bone density and FFM, for 14,815 participants. Comparing extreme quintiles of these risk
factors revealed a 68%, 67% and 44% reduction in total fractures for BUA, VOS and FFM, respectively
(mean follow-up time 17.4 years). Likewise, extreme quintiles of BUA and VOS were associated with a
69% and 67% reduction in hip fractures, with no significant reductions by FFM. Earlier research in
this cohort with a mean follow-up of 1.9 years reported that a 1 SD difference in BUA (equivalent to
20 db/MHz) and VOS (equivalent to 40 m/s) was associated with a relative risk of fracture of 1.95 and
1.63, respectively [19] and analysis in a subset (n = 1151) over 10 years showed that a 1 SD decrease
in BUA was associated with a hazard ratio of 2.0 [20]. Together, research in this cohort suggests that
maintaining BUA, VOS and FFM is an important preventative target for fracture risk.
Previous research on these particular risk factors (BUA, VOS and FFM) and Mediterranean diet
adherence is limited. A study of 418 Italian healthy men and women showed positive associations
between higher Mediterranean diet adherence and higher quantitative ultrasound index [34]. In 198
university students, adherence to the Mediterranean Diet Quality Index was associated with higher
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FFM assessed using BIA [35]. Analysis of 7961 women recruited to the Women’s Health Initiative
study found no associations between aMED adherence and bone mineral density or lean body mass
measured using dual-energy x-ray absorptiometry (DXA) [15], although our previous analysis of
2570 women from the TwinUK cohort showed higher MDS adherence was associated with lower
fat free mass measured using DXA [16] and analysis of 2371 Chinese adults found higher aMED
scores were positively and dose-dependently associated with DXA-measured bone mineral density at
multiple sites [17].
Although adherence to both the aMED and MDS was associated with reduced fracture risk, the
effect sizes were stronger for aMED adherence. One of the key differences between the scores was
differential scoring of dairy intakes, which resulted in higher calcium intakes with high adherence
to the aMED and lower calcium intakes with higher MDS adherence. However, notably, when we
examined the individual components of the score, dairy intake did not appear to be a significant factor
in predicting fracture risk in this cohort. We suggest that future studies detail the components of the
MDS used to ensure the appropriate interpretation of their results.
Strengths of our study include the wide age range of both men and women followed for 17 years
and the large number of fractures (n = 2195) ascertained without self-report. This was the first
study to use food diaries to measure Mediterranean diet adherence and although our results are
comparable to fracture studies using food frequency questionnaires this provides useful information
for future studies planning to measure diet quality scores. In addition, this was, to our knowledge,
the largest cross-sectional study to examine associations between Mediterranean diet adherence,
bone density and FFM in both men and women. Whilst DXA measured is regarded at the gold
standard assessment method for bone density and body composition, recent research suggests that
whilst BIA overestimates FFM compared to DXA, the methods are interchangeable at a population
level [36] and calcaneus ultrasonography is predictive of bone quality as measured by DXA [37] and
produced comparable fracture risk predictions as DXA in this cohort [20]. In addition, we were able
to relate FFM to fracture risk for the first time in this cohort therefore demonstrating the potential
importance of FFM as a preventative target for fracture risk. Despite the strengths of this study, there
are also some limitations, the food diaries were completed once at baseline and we cannot exclude the
possibility that dietary changes occurred during follow-up. Although we expected that the number
of high-trauma fractures would be low, we were not able to exclude these cases. We also had no
functional measures of sarcopenia which, alongside muscle mass, is an important element of disease
definition [38]. Finally, even though we adjusted for a range of important confounding factors, we
cannot exclude the possibility of residual confounding.
In conclusion, we have shown for the first time that Mediterranean diet adherence assessed using
food diaries is associated with fracture risk at a similar magnitude to studies using food frequency
questionnaires. We found that few of the individual components of the Mediterranean diet adherence
scores were associated with fracture risk, indicating that in this non-Mediterranean region the additive
effects of individual components within the Mediterranean diet have a greater effect. This evidence
supports the need to develop interventions to enhance Mediterranean diet adherence, particularly in
women, where evidence for associations was stronger.
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in 25,450 men and women aged 39–79 year; Table S3: Fat free mass (kg) by quintile of Alternative Mediterranean
Diet Score and Mediterranean Diet Score in 14,720 men and women aged 42–82 year, stratified by sex; Table S4:
Measures of broadband ultrasound attenuation, velocity of sound and fat free mass by quintile of alternative
Mediterranean Diet Score in 14,815 men and women aged 42–82 year, stratified by sex; Table S5: Measures
of broadband ultrasound attenuation, velocity of sound and fat free mass by quintile of Mediterranean Diet
Score in 14,815 men and women aged 42–82 year, stratified by sex; Figure S1: Total fracture risk after a mean
follow up of 17.6 years by quintile of alternative Mediterranean Diet Score and Mediterranean Diet Score in
8351 post-menopusal women aged 40–78 year. Figure S2: Total fracture risk after a mean follow up of 17.6 years
by quintile of aMED and MDS in 25,450 men and women aged 39–79 year.
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